American Regent Inc
General
Total Cases63
Active Cases9
Patents22
Ratings
Experience
Grade
Trend
DCT
L4
E
PTAB
L5
E
CAFC
--
--
--
Analytics
Cases
Litigated Patents
Ratings Trends
Recent Dockets
Entered | Case | Description |
|---|---|---|
| 02/20/25 | Summons Issued as to Apotex Inc. on 2/20/2025. (mrr) (Entered: 02/20/2025) | |
| 02/20/25 | Summons Issued as to Apotex Corp. on 2/20/2025. (mrr) (Entered: 02/20/2025) | |
| 02/20/25 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Daiichi Sankyo, Inc., Other Affiliate Daiichi Sankyo Company, Limited, Other Affiliate Daiichi Sankyo U.S. Holdings, Inc. for American Regent, Inc. filed by American Regent, Inc., Vifor (International) AG. (mrr) (Entered: 02/20/2025) | |
| 02/20/25 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent CSL Limited for Vifor (International) AG filed by American Regent, Inc., Vifor (International) AG. (mrr) (Entered: 02/20/2025) | |
| 02/20/25 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,612,109; 7,754,702; 8,895,612; 11,364,260 ; 11,433,091; 11,478,502. (Attachments: # [1] Patent Report 2)(mrr) (Entered: 02/20/2025) | |
| 02/20/25 | Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 01/10/2025. Date of Expiration of Patent: See Attachment.Thirty Month Stay Deadline: 7/10/2027. (mrr) (Entered: 02/20/2025) | |
| 02/20/25 | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mrr) (Entered: 02/20/2025) | |
| 02/20/25 | COMPLAINT for Patent Infringement against Apotex Corp., Apotex Inc. (Filing fee $ 405, receipt number ADEDC-4619280) - filed by Vifor (International) AG, American Regent, Inc. (Attachments: # [1] Exhibits A-G, # [2] Civil Cover Sheet)(mrr) (Entered: 02/20/2025) | |
| 02/19/25 | Case Assigned to Judge Gregory B. Williams. Please include the initials of the Judge (GBW) after the case number on all documents filed. (nms) (Entered: 02/19/2025) | |
| 02/18/25 | Summons Issued as to Meitheal Pharmaceuticals, Inc. on 2/18/2025. (mrr) (Entered: 02/18/2025) |